Norendoxifen

Norendoxifen
Clinical data
Other names	4-Hydroxy-N,N-didesmethyltamoxifen
Identifiers
	IUPAC name 4-[(Z)-1-[4-(2-Aminoethoxy)phenyl]-2-phenylbut-1-enyl]phenol;
JSmol)	Interactive image;
	SMILES CCC(=C(c1ccc(cc1)O)c2ccc(cc2)OCCN)c3ccccc3;
	InChI InChI=1S/C24H25NO2/c1-2-23(18-6-4-3-5-7-18)24(19-8-12-21(26)13-9-19)20-10-14-22(15-11-20)27-17-16-25/h3-15,26H,2,16-17,25H2,1H3; Key:YCQBLTPGQSYLHD-UHFFFAOYSA-N;

Norendoxifen, also known as 4-hydroxy-N,N-didesmethyltamoxifen, is a

4'-hydroxynorendoxifen, have been developed from norendoxifen, and may have therapeutic potential as antiestrogens in the treatment of estrogen receptor-positive breast cancer.^[2]

References

^
S2CID 22096941
.

PMID 25751283
.

genito-urinary system is a stub. You can help Wikipedia by expanding it.
v
t
e

drug article is a stub. You can help Wikipedia by expanding it.
v
t
e

[pmid21814747-1] 
S2CID 22096941
.

[pmid25751283-2] PMID 25751283
.

[2]

See also

References